HLHuikun Liu

Huikun Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huikun Liu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early gestational weight gain and birth weight outcome: a Chinese population-based cohort

    by Shuang Zhang, Lingyan Feng, Weiqin Li, Nan Li, Leishen Wang, Jia Guo, Jinnan Liu, Junhong Leng, Peng Wang, Huikun Liu

    Background: Early gestational weight gain (E-GWG) plays a crucial role in fetal development. Its timing and sex-specific impacts have not been thoroughly investigated, especially in Asian populations. Methods: In this retrospective cohort study, 66,291 mother-infant pairs from the Tianjin Women and Children’s Health Care System were analyzed. Linear and logistic regression models were applied to examine the association between E-GWG and birth weight outcomes across BMI groups. We also analyzed the effects of E-GWG on the birth weight of infants born to pregnant women carrying male and female fetuses, respectively. Results: E-GWG had a stronger impact on birth weight z-scores than late GWG ( β 0.038 vs. 0.016, P < 0.001). In each BMI subgroup, E-GWG was positively correlated with the risk of LGA and negatively correlated with the risk of SGA (all P < 0.001). The lower the prepregnancy BMI, the more sensitive the birth weight outcomes were to the variation in E-GWG and full-term GWG. The equivalent increase of E-GWG has different effects on the birth weight of male or female newborns. A female newborn has a higher risk of LGA at birth than a male in the underweight, overweight, and obesity group ( P < 0.05). Girls’ mothers with low pre-pregnancy weight combined with E-GWG less than 10.7 kg had a particularly high risk of SGA. Male newborns have a higher risk of SGA than females with the same insufficient E-GWG in the normal weight and overweight groups. When the E-GWG of mothers with obesity was less than 3.0 kg, the SGA risk was increased for both male (OR 1.764, 95% CI 1.003-3.104) and female newborns (OR 2.540, 95% CI 1.364-4.729) compared with E-GWG more than 8.0 kg. Conclusions: Insufficient E-GWG of women with underweight highlights the risk of female SGA. Pregnant women with excessive E-GWG should be aware of the risk of LGA, especially those carrying female fetuses. Impact: Early GWG showed stronger impacts on birth weight outcomes (LGA/SGA) than late GWG, with BMI/sex effects. Female fetuses showed higher LGA odds with excessive E-GWG in moms with overweight/obesity; insufficient E-GWG in moms with underweight strongly correlated with female-specific SGA vulnerability. Findings warrant BMI/sex-tailored GWG guidelines to optimize Asian perinatal health and reduce long-term metabolic risks.


  • Open Access

    Effects of a Lifestyle Intervention in Young Women with GDM and Subsequent Diabetes

    by Gang Hu, Huikun Liu, Junhong Leng, Leishen Wang, Weiqin Li, Shuang Zhang, Wei Li, Gongshu Liu, Huiguang Tian, Shengping Yang, et al.

    The purpose of this study was to examine whether a 9-month intensive lifestyle intervention could lead to weight loss and improve cardiovascular risk factors among young women with both gestational diabetes mellitus (GDM) and newly diagnosed diabetes. A total of 83 young women, who had GDM and were subsequently diagnosed as type 2 diabetes at an average of 2.6 years after delivery, participated in a 9-month intensive lifestyle intervention and a follow-up survey at 6–9 years postintervention. After the 9-month intervention, these women had a weight loss of 2.90 kg (−4.02% of initial weight), decreased waist circumference (−3.12 cm), body fat (−1.75%), diastolic blood pressure (−3.49 mmHg), fasting glucose (−0.98 mmol/L) and HbA1c (−0.72%). During the 6–9 years postintervention period, they still had lower weight (−3.71 kg; −4.62% of initial weight), decreased waist circumference (−4.56 cm) and body fat (−2.10%), but showed a slight increase in HbA1c (0.22%). The prevalence of using glucose-lowering agents increased from 2.4% at baseline to 34.6% after the 9-month lifestyle intervention, and to 48.4% at 6–9 years postintervention. A 9-month intensive lifestyle intervention can produce beneficial effects on body weight, HbA1c and other cardiovascular risk factors among young women with previous GDM who subsequently developed new diabetes.